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Vaginal carcinoma is an uncommon malignancy and one of the few gynecologic malignancies that
is still clinically staged. Clinical staging, which can be difficult in some instances, is potentially in-
accurate, as it has been shown to be in early endometrial and ovarian carcinoma. In addition, clini-
cal stagingcan result in over- orundertreatmentofthe disease.The lackofstandardizationoftreatment
furthercompounds the issue, particularly for patients with small-volume disease.We report three pa-
tients with grade 2 or 3 small-volume primary squamous cell carcinoma of the vagina who under-
went pelvic lymph node sampling for staging purposes. Each patient had lesions small enough to be
considered for brachytherapy only. An average of 12 lymph nodes were removed with an average
operative time of 72 minutes. All procedures were performed on an outpatient basis, and there were
no intraoperative or postoperative complications. In one patient, teletherapy was added to the
brachytherapy because a microscopic focus of squamous cell carcinoma was discovered in an obtu-
rator lymph node. Our initial experience indicates that laparoscopic sampling oflymph nodes in pa-
tients with early vaginal carcinoma may be helpful in preventing undertreatment of these women.
Individualization of treatment can be accomplished quickly and safely on an outpatient basis, and
initiation of treatment is not delayed. We believe further evaluation of laparoscopic staging of pri-
mary vaginal carcinoma is indicated.
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INTRODUCTION
Primary carcinoma of the vagina is an uncommon gyneco-
logic malignancy. The small number ofpatients seen at any
one institution has made standardization of treatment diffi-
cult. Currently, patients with early disease are treated either
with surgery or brachytherapy alone or with a combination
of brachytherapy and teletherapy (Ball and Berman, 1982;
Perez et al., 1973; Marcus et al., 1978). The need for exter-
nal radiation to treat nodal metastases remains unclear.
Most gynecologic malignancies are now surgically
staged. Analysis oftreatment results is believed tobe more
accurate using surgical staging. In addition, ind;_vidualiza-
tion of treatment is based on a more accurate assessment
ofdisease status. Surgical staging ofvaginalcarcinomahas
not been reported despite existing controversy on the ideal
management of patients with early disease.
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Operative laparoscopy recently has been used to stage
patients with other gynecologic malignancies (Childers et
al., 1992); Childers, Brzechffaet al., 1993; Querleu, 1993;
Childers, Tran et al., 1993). Initial reports indicate that
this minimally invasive surgical approach is safe, ade-
quate, and may be advantageous for the patient.
We report the results of three patients with stage I pri-
mary squamous cell carcinoma of the vagina who were
surgically stagedby laparoscopic pelvic lymph node sam-
piing. All patients were considered candidates for
brachytherapy only.
MATERIALS AND METHODS
BetweenJuly 1992andJuly 1993, three patients with stage
I squamous cell carcinoma of the vagina were considered
candidates for laparoscopic pelvic lymph node sampling.
All three patients had small lesions (2-3 cm) located in
the upper vagina. Two patients had anterior wall lesions,
and one had a left-sided lesion. The tumors were poorly
differentiated in two patients and moderately well differ-
entiated in the third (See Table 1).118 J. CHILDERS et al.
Table I
Patient
Age Weight Tumor Tumor Tumor
(years) (pounds) size(cm) location grade
Hospital Operative
Nodes stay time
Number Status (days) (minutes)
53 162 2 x 2 Anterior
upper 1/3
2 47 145 2 x 2 Anterior
upper 1/3
3 75 134 2 x 3 Left wall
upper I/3
The patients were 47, 53, and 75 years ofage; none was
obese, and all were in good medical health. One patient
(no. 2) had aprevious hysterectomy, whichwas performed
for benign reasons. Both younger patients were smokers.
The patients were counseled regarding management
options, including brachytherapy alone, combined
brachytherapy and teletherapy, or radiation therapy based
on the presence or absence of metastatic disease in their
pelvic lymph nodes removed via laparoscopy.
Each patient received a mechanical bowel preparation
consisting oftwo days ofclear liquids and 240mL ofmag-
nesium citrate each day fortwo days before the procedure.
All were admitted on the morning of surgery, and all pro-
cedures were performed with the patient in the supine po-
sition under general anesthesia. No prophylactic
antibiotics were administered. Prior to lymphadenectomy,
the two patients with anterior vaginal wall lesions under-
went urethroscopy and cystoscopy.
The four-trocar technique, as previously described, was
used in all cases (Childers et al., 1992). The round liga-
ment was not transected in the two patients with uteri in
situ. Pelvic washings were obtained for cytology before
the lymphadenectomy was performed. A bilateral
0 One microscopic 0 45
positive
7 Negative 0 105
18 Negative 0 65
transperitoneal pelvic lymph node sampling was per-
formed in all three patients, as previous described
(Childers et al., 1992). No peritoneal closures were per-
formed, and no retroperitoneal drains were placed.
RESULTS
Laparoscopic staging was successfully accomplished in
all three patients. Estimatedblood loss was 50mL foreach
procedure, and there were no intraoperative, early, or late
postoperative complications. None of the lymphatic tis-
sue removed was grossly suspicious for metastatic carci-
noma. The lymph node count ranged from 7 to 18, with
an average of I 1.7. Microscopically, all nodes were neg-
ative except one left obturator node in patient no. 1, which
contained microscopic squamous cell carcinoma.
Operative times ranged from 45 to 105 minutes, with an
average of 72. All patients were discharged on the day of
surgery. Each patient subsequently underwent intracavi-
tary radiotherapy. External-beam radiotherapy was added
for patient no. 1 because of the obturator lymph node that
contained metastatic disease. Thus far, no patient has had
recurrence of disease, and patients no. and 2 are more
than one year postsurgery.
Figure 1 The fight retropefitoneal space after a transperitoneal
laparoscopic pelvic lymphadenectomy. The hypogastric superiorvesicle
and uterine artery can clearly be seen. The obturator nerve is seen exiting
behind the internal and external iliac veins and disappearing into the
obturator fossa.
DISCUSSION
Thetreatmentofprima,yvaginalcarcinoma, arelatively rare
neoplasm of the female genital tract, has not been stan-
dardized (Perez et al., 1982). The disease Accounts for only
1-2% ofall gynecologic cancers, making it difficult to study
patients prospectively. The rarity of this malignancy also re-
quires retrospective analysis to span several decades. The
changesinradiationequipmentandtechniquesoverthistime
make interpretation of data at a single institution and com-
parison of results from various institutions difficult.
Patients with stage I disease traditionally have done
well. Currently, five-year survivals of 70% to 100% are
being reported (Nori et al., 1983; Prempree, 1982;LAPAROSCOPIC OF EARLY VAGINAL CARCINOMA STAGING 19
Puthawala et al., 1983; Benedet et al., 1983; Gallup et al.,
1987; Pride et al., 1979; Rubin et al., 1985; Spirtos et al.,
1989). The tumor control and survival that these patients
enjoy is often achieved with brachytherapy alone. Many
authors advocate treating some patients with intracavitary
and/or interstitial sources alone (Brown et al., 1971;
Rutledge, 1967; Perez and Camel, 1982). Perez et al. re-
ported the same tumor control in the pelvis of stage le-
sions with or without the addition of external-beam
radiotherapy (Perez and Camel, 1982).
Even some patients with stage II disease have been
treated with brachytherapy alone. Perez et al. advocated a
modification of the International Federation of
Gynecology and Obstetrics (FIGO) staging system to sep-
arate patients with stage II disease who do not need exter-
nal-beam radiotherapy. The authors believe that patients
with stage IIA disease (subvaginal infiltration not involv-
ing the parametrium) can be treated with brachytherapy
alone, whereas patients with stage liB disease (parametrial
infiltration not involving the pelvic wall) require the addi-
tion of external-beam radiotherapy to reduce tumor size
and sterilize disease in pelvic lymphatics. Pride et al., using
this staging modification retrospectively, reported a 65%
five-year survival rate for patients with stage IA and IIA
disease. This rate dropped to 31% for patients with stage
liB disease (Pride et al., 1979).
Vaginal carcinoma is one of the few gynecologic ma-
lignancies that is still clinically staged. Even using the
Perez-modified FIGO staging, the limitations of clinical
staging are obvious. This classification system does not
take into account the status of regional lymph nodes. The
limitations oftraditional radiologic imaging techniques in
detecting metastatic lymph node involvement are well
known. These limitations in clinical staging possibly
could account for the wide variation reported in the liter-
ature of survival rates and stage distribution.
Currently, the management of primary squamous cell
carcinoma of the vagina is individualized. Factors such as
previous irradiation, stage, size, location, and tumor grade
are important considerations. The addition oflymph node
status would allow even further individualization of ther-
apy. With this information, the decision to treat patients
with small-volume disease with local treatment only
(brachytherapy or surgery) would be based on more sound
scientific information. Only patients with lymph nodes
containing metastatic disease then would be treated with
external-beam radiotherapy.
Lymph node sampling in patients with vaginal carci-
noma could be performed in a number of ways. The
transperitoneal technique we used currently is a popular
method of laparoscopic lymphadenectomy. However, a
retroperitoneal approach, whether or not endoscopic,
could easily be employed and may offer an advantage to
the patient who subsequently receives teletherapy.
Inguinal nodes should be sampled in patients with distal
vaginal involvement.
We believe that surgical staging may benefit patients
with primary vaginal carcinoma just as it has for patients
with early vulvar, endometrial, and ovarian carcinoma.
Our initial experience with laparoscopic staging of stage
primary squamous cell carcinoma ofthe vagina indicates
that the additional information obtained aids in individu-
alization of treatment, possibly allowing for lower mor-
bidity and an improved survival rate. Our data support
further investigation into the surgical staging of primary
vaginal carcinoma.
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